On January 29, 2019, the Board of Directors of Genomic Health, Inc. elected Barry P. Flannelly to serve as a member of the Board of Directors of the company effective on April 16, 2019. In addition, Dr. Flannelly will serve on the Audit Committee of the Board of Directors. Dr. Flannelly has served as Executive Vice President and General Manager US of Incyte Corporation, a biopharmaceutical company, since June 2015 and served as Executive Vice President, Business Development and Strategic Planning of Incyte from August 2014 to June 2015.